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Abstract
Multidrug-resistant and New Delhi metallo-b-lactamase 1
(NDM-1) -producing Acinetobacter baumannii are increasingly
reported. A collection of ﬁve NDM-1-positive A. baumannii iso-
lates recovered in four European countries were analysed.
Genotyping was performed by pulsed-ﬁeld gel electrophoresis,
multiplex PCR sequence typing, Diversilab and multilocus
sequence typing. Three distinct sequence types were identiﬁed.
All isolates harboured a chromosomally located blaNDM-1 gene
within a Tn125-like transposon. One isolate co-expressed
another unrelated carbapenemase OXA-23. This report consti-
tutes the ﬁrst epidemiological study of NDM-1-producing A. bau-
mannii from four countries.
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Acinetobacter baumannii is an opportunistic pathogen that is
an important source of nosocomial infections, mostly pneu-
monia [1]. The treatment of infections due to this microor-
ganism is becoming a serious clinical concern because
A. baumannii is frequently resistant to multiple antibiotics [2].
Resistance to carbapenems in A. baumannii is mostly related
to the production of carbapenem-hydrolysing class D b-lacta-
mases and to a lesser extent to metallo-b-lactamases [2].
Recent reports showed that the blaNDM-1 gene encoding
New Delhi metallo-b-lactamase 1 (NDM-1) is spreading
worldwide among gram-negative bacteria [3]. The blaNDM-1
gene was initially identiﬁed in Klebsiella pneumoniae and Esc-
herichia coli isolates but has been additionally reported in
many other Gram-negative rods [3,4]. In particular, the
blaNDM-1 and blaNDM-2 genes have been recently identiﬁed
in A. baumannii [5–9] and in other Acinetobacter species
[10,11]. Notably, both genes have been identiﬁed as located
on the same composite transposon named Tn125, being
10 099-bp long and comprising two copies of an identical
insertion sequence ISAba125 bracketing the blaNDM-1/-2
genes [12,13].
Our study aimed to study the clonal relationship of NDM-
1-producing A. baumannii and the genetic context of blaNDM-1
responsible for dissemination of this resistance trait, by anal-
ysing a collection of blaNDM-1-positive A. baumannii isolates
recovered from different European countries. Isolate 161/07
was recovered in Germany in 2007 with a Balkan origin [5],
isolate Slo was from a respiratory sample taken in Slovenia
in 2008, isolate JH was collected in Switzerland in 2010 with
a Balkan origin [12], and the two remaining isolates were
isolated in France in 2011, one of those two being imported
in France from Algeria (Table 1) [14].
The isolates were identiﬁed by 16S rRNA gene sequencing
[15]. Susceptibility testing was performed by disc-diffusion
assay (Sanoﬁ-Diagnostic Pasteur, Marnes-la-Coquette, France)
and interpreted according to updated CLSI guidelines [16].
The MICs of b-lactams including imipenem, meropenem and
doripenem were determined by Etest (AB bioMe´rieux; Solna,
Sweden) as described previously [17]. All isolates were resis-
tant to b-lactams including carbapenems (Table 1). The pro-
duction of metallo-b-lactamases was assessed using a
combined disc-test, based on the inhibition of the metallo-b-
lactamase activity by EDTA as described elsewhere [18]. All
isolates were positive for the production of metallo-b-lacta-
mases. The PCR experiments performed to detect carbape-
nemase genes as described previously [19], followed by
sequence analysis, led to the identiﬁcation of the blaNDM-1 gene
in the ﬁve isolates in addition to naturally occurring blaOXA-51-
like genes (respectively encoding OXA-64, OXA-69 or OXA-
94) (Table 1). In addition, the blaOXA-23 gene, coding for the
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unrelated carbapenemase OXA-23, was identiﬁed in isolate
JH, as found previously in one Indian A. baumannii isolate [12].
To determine the genetic location of the blaNDM-1 gene,
the plasmid DNA of the different A. baumannii isolates was
extracted by using the Kieser technique [20] and Southern
hybridization was performed by using internal PCR-obtained
amplicons as probe for the blaNDM gene. DNA hybridization
gave negative results, suggesting that the blaNDM-1 gene was
chromosomally located in all isolates (data not shown). Trans-
fer of the ticarcillin-resistance marker into A. baumannii
BM4547 was attempted by liquid mating-out assays at 37C
and by electroporation of a plasmid DNA suspension
extracted from A. baumannii clinical isolate into A. baumannii
BM4547. It gave negative results, reinforcing the hypothesis of
a chromosomal location of the blaNDM-1 gene in all isolates.
The genetic context of blaNDM-1 gene was determined by
PCR mappings or by shotgun clonings using HindIII-restricted
genomic DNA and the HindIII-restricted pBK-CMV plasmid
as described previously [17]. Recombinant plasmids were
selected onto Trypticase soy agar plates containing ticarcillin
(100 mg/mL) and kanamycin (30 mg/mL). Sequencing of the
recombinant plasmids showed that the blaNDM-1 gene was
located in a transposon Tn125 [12]. In isolate JH, transposon
Tn125 was inserted into a chromosomal gene encoding a
putative protein of A. baumannii and surrounded by a 3-bp
duplication (TTG) being the signature of the transposition
process. In isolates SLO and 161/07, Tn125 was inserted in a
gene encoding a major facilitator superfamily transporter
protein (CTG duplication). In the two remaining isolates
(StN and Ora-1), Tn125 was truncated at its righthand
extremity by insertion sequence ISAba14 located upstream
of the dct gene, giving rise to a truncated Tn125 (DTn125)
(Table 1; Fig. 1). Further PCR assays did not identify a sec-
ond copy of ISAba125, suggesting that Tn125 was no more
functional in that latter structure.
Genotypic comparison was performed by multilocus
sequence typing as described by Diancourt et al. [21], by
sequence-type multiplex PCR [22], by DiversiLab following
TABLE 1. Features of NDM-1 producing Acinetobacter baumannii
A. baumannii
isolates
Country of
isolation
Year of
isolation Sample
Carbapenemase
genotyping
MICsc
ECa//STb Pulsotype Support
Genetic
vehicleCTX CAZ IPM MEM DOR
JH Switzerland 2010 Rectal swab NDM-1, OXA-23,
OXA-69
>256 >256 >32 >32 >32 I/1 A Chromosomal Tn125
Slo Slovenia 2008 Respiratory
sample
NDM-1, OXA-64 >256 >256 >32 >32 >32 nt/25 B Chromosomal Tn125
161/07 Germany 2007 Skin,
respiratory
sample
NDM-1, OXA-64 >256 >256 >32 >32 >32 nt/25 B Chromosomal Tn125
Ora-1 France 2011 Rectal swab NDM-1, OXA-94 >256 >256 >32 >32 >32 nt/85 C Chromosomal DTn125
StN France 2011 Rectal swab NDM-1, OXA-94 >256 >256 >32 >32 >32 nt/85 C Chromosomal DTn125
aMultiplex PCR for determining the clonal complex [22].
bMulti-locus sequence typing [21].
cCTX, cefotaxime; CAZ, ceftazidime; IPM, imipenem; MEM, meropenem; DOR, doripenem.
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FIG. 1. Schematic representation of transposon Tn125 carrying the blaNDM-1 gene. Genes and their transcription orientations are indicated by
arrows. The lengths of the target genes and the exact location of the target site are not to scale. The oriIS of ISCR21 is indicated by a circle.
Gene names are abbreviated according to their corresponding proteins: iso for phosphoribosylanthranilate isomerase; tat for twin-arginine trans-
location pathway signal sequence protein; dvt for divalent cation tolerance protein; Dpac for truncated phospholipid acetyltransferase. IRL and
IRR are for inverted repeat left and right, respectively. The Tn125 complete was found in isolates JH, Slo and 161/07 and the truncated isoform
of Tn125 (DTn125) was found in isolates Ora-1 and StN.
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the manufacturer’s instructions (bioMe´rieux, La Balme-les-
Grottes, France), and by pulsed-ﬁeld gel electrophoresis as
described [23]. The pulsed-ﬁeld gel electrophoresis analysis
showed that the ﬁve isolates were grouped into three dis-
tinct clones named A to C (Table 1), with strains Ora-1 and
StN (from France) sharing identical patterns, strains Slo
(from Slovenia) and 161/07 (from Germany) being clonally
related according to the Tenover’s criteria (two bands of dif-
ference) [24], and strain JH (from Switzerland) belonging to
a different clone. Analysis by the Diversilab technique
resulted in the same interpretation (Fig. 2). Further analysis
with sequence-type multiplex PCR showed that isolate JH
belonged to European clone I although other isolates did not
correspond to any deﬁned European clone (Table 1). Mul-
tilocus sequence typing analysis showed that isolate JH
belonged to ST1, isolates Slo and 161/07 belonged to ST25,
and the two remaining isolates belonged to ST85 (Table 1).
ST1-type isolates are widely distributed throughout the
world whereas ST25 and ST85 strains have been rarely
reported (http://www.pasteur.fr/cgi-bin/genopole/PF8/mlstdb-
net.pl?ﬁle=acin_isolates.xml).
In conclusion, this report highlights scattered diffusion of
NDM-1 producing A. baumannii in Europe from the west to
the east. This dissemination was neither due to a single clone
nor to any plasmid diffusion but rather to different clones
carrying the transposon Tn125 or Tn125-derivatives which
are truncated. While this study was in progress, two NDM-
1-producing A. baumannii were isolated in Belgium and Czech
Republic, [25,26]. The clinical isolate from the Czech Repub-
lic belonged to ST1, similar to isolate JH from Switzerland;
whereas the clinical isolate from Belgium belonged to Euro-
pean clone II (whichcorresponds to ST2 in the multilocus
sequence typing Pasteur Institute scheme) [25,26]. These
two reports reinforce the fact that the spread of the blaNDM-
1 gene in A. baumannii is not linked to a clonal spread but to
the spread of a genetic structure. The spread of transposon
Tn125 in Acinetobacter species harbouring blaNDM genes mir-
rors what has been observed with the blaKPC carbapenemase
gene, which is associated with transposon Tn4401 [27].
Interestingly, we report here the ﬁrst occurrence of an
NDM-1 producer in Slovenia and therefore further conﬁrm
that Balkan countries constitute a signiﬁcant reservoir for
NDM-1-producing bacteria.
Nucleotide Sequence Accession Number
The nucleotide sequence data of the DTn125 reported in
this work has been deposited in the GenBank nucleotide
database under accession no. JX000237.
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